Aline Schindelé
Clinical Development Director
Pharmacist with 18 years of clinical research experience, in both Biotech and mid-size CROs
-
15 years of clinical project management in various indications & study phases (Phase I-II to pivotal Phase III)
-
Geographical reach: Asia, Europe, and the USA
-
-
Clinical advice to support biotechnological companies including conduct of clinical gap analysis, preparation of RFP, CRO selection and oversight, set-up clinical quality procedures and tools, and strategic clinical input
-
Complete management of all clinical trial activities including vendor management
-
Experience in Regulatory Inspections (Europe & USA)
-
3 years of clinical trial monitoring
Experience
-
mAb therapy - Phase II & III in ovarian and breast cancer; North America, Europe & Asia
-
TKI - Phase II in multiple myeloma, autoimmune & inflammatory diseases; France
-
Gene therapy - Phase I/II in rare disease; France
-
GMO Vaccine - Phase I/II in HIV; Europe
-
Cell therapy - Phase I/II in leukemia; USA
-
mAb therapy - Phase II in Acute Ischemic Stroke; Europe
-
Immune desensitization therapy - registration Phase III; Canada, USA, Europe & Australia